ProfileGDS5678 / 1451129_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 7% 7% 7% 6% 6% 7% 6% 6% 7% 6% 6% 6% 6% 6% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.171227
GSM967853U87-EV human glioblastoma xenograft - Control 22.135417
GSM967854U87-EV human glioblastoma xenograft - Control 32.138067
GSM967855U87-EV human glioblastoma xenograft - Control 42.083986
GSM967856U87-EV human glioblastoma xenograft - Control 52.075116
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.185967
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.133256
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.117576
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.115777
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.120626
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.120066
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.107586
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.125946
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.126266